+1-888-771-6965
Log In / Register

Your Shopping Cart

Contains 0 items
Total: $0.00
View Shopping Cart
  • fda-import-program-2019-seminar-training
  • raw-material-requirements-health-canada-usp-ep-in-a-cgmp-environment-issues-and-solutions-

Webinars

View More »

Contract Research Organizations Monitoring Essentials for Sponsors

  • Kevin Denny
  • Jul 23, 2019

GxP/GMP Requirements and its Consequences for Documentation and Information Technology Sys ....

  • Eleonora Babayants
  • Jul 23, 2019

The GxP Internal Audit Report: An Interpretation

  • William D Fox
  • Jul 24, 2019

Process Validation - Overview of Why and How

  • Betty Lane
  • Jul 24, 2019

Quality Control for Microbiological Media and Reagents

  • Todd Graham
  • Jul 24, 2019

Biosafety and Blood Borne Pathogen Safety in the Lab

  • Danielle DeLucy
  • Jul 25, 2019

The Regulatory Expectations for Environmental Monitoring Programs

  • Kenneth Christie
  • Jul 25, 2019

Reducing memory and attention failures/errors: Understanding Cognitive Load

  • Ginette M Collazo
  • Jul 25, 2019

Health Canada Medical Device Regulations (SOR/98-202)

  • Winkie Wong
  • Jul 29, 2019

Advertising And Promotional Material Compliance And Review Process

  • Peggy Berry
  • Jul 29, 2019

Post Market Surveillance with the new Medical Device Regulation EU MDR 745/2017

  • Frank Stein
  • Jul 29, 2019

Developing a Strategic Approach to FDA Compliance for Computer Systems

  • Carolyn Troiano
  • Jul 31, 2019

Orphan Drug Development History & Overview

  • Peggy Berry
  • Aug 9, 2019

The Impact of ICH E6 R2

  • Pam Dellea Giltner
  • Aug 13, 2019

Developing Practical and Successful GCP and GVP Audit & Inspection CAPAs

  • Penelope Przekop
  • Aug 26, 2019

State of the Art: Recommendations for writing a thorough SOA and build SOA Libraries for y ....

  • Maria Sanchez
  • Aug 27, 2019

Specification and OOS for Pharma, Biopharma and Combination Products

  • Tanvir Mahmud
  • Aug 28, 2019

Pharmaceutical Water System: Design, Testing and Data Management

  • Charity Ogunsanya
  • Aug 29, 2019

What to Expect from FDA's Approach to Regulate Medical Software

  • Dennis Weissman
  • Aug 29, 2019

Comparability Protocols For Approved Drugs

  • Peggy Berry
  • Sep 17, 2019

Technical Writing in an Industrial Environment

  • Robert Peoples
  • Sep 19, 2019

Recognizing and Responding to "Red Flags" in Clinical Operations

  • Peggy Berry
  • Sep 24, 2019

Seminars

View More »

PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation

  • Penelope Przekop
  • San Francisco, CA | July 22-23, 2019

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

  • Andrew Campbell
  • Tampa, FL | August 1-2, 2019

Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices

  • Darshan Kulkarni
  • San Diego, CA | August 8-9, 2019

FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials

  • Peggy Berry
  • San Francisco, CA | August 15-16, 2019

Quality Control Laboratory Compliance - cGMPs and GLPs

  • Kelly Thomas
  • Philadelphia, PA | August 19-20, 2019

Latin America: Regulatory Compliance Requirements for Life Science Products (Focus: Brazil, Mexico, Argentina)

  • Robert J Russell
  • Philadelphia, PA | August 29-30, 2019

Managing Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an Inspection

  • Rita Hoffman
  • San Diego, CA | September 12-13, 2019

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR

  • David Nettleton
  • Philadelphia, PA | September 26-27, 2019

21 CFR Part 11 Compliance for SaaS/Cloud Applications

  • David Nettleton
  • Philadelphia, PA | September 26-27, 2019

Designing and Sustaining New and Existing Product Stability Testing Program

  • Charity Ogunsanya
  • Philadelphia, PA | September 26-27, 2019

Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions

  • Barry A Friedman
  • San Diego, CA | October 3-4, 2019

FDA's New Import Program for 2019 - Strict Precision

  • Casper Uldriks
  • Houston, TX | October 17-18, 2019
  • reduce-costs-for-compliance-with-data-integrity
  • quality-control-laboratory-compliance-cgmps-and-glps

You Recently Viewed